Encompass Health Co. (NYSE:EHC) Given Average Rating of “Buy” by Analysts

Shares of Encompass Health Co. (NYSE:EHC) have received an average rating of “Buy” from the eleven analysts that are covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $107.11.

Several brokerages recently issued reports on EHC. Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp raised their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Barclays upped their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. UBS Group raised their target price on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Finally, Royal Bank of Canada upped their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th.

Encompass Health Stock Performance

EHC opened at $102.87 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The business has a fifty day simple moving average of $98.61 and a 200 day simple moving average of $91.77. Encompass Health has a 1 year low of $64.15 and a 1 year high of $104.55. The company has a market capitalization of $10.36 billion, a PE ratio of 24.85, a price-to-earnings-growth ratio of 1.36 and a beta of 0.86.

Encompass Health (NYSE:EHC) last announced its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the previous year, the business posted $0.86 earnings per share. Encompass Health’s quarterly revenue was up 11.9% on a year-over-year basis. Research analysts expect that Encompass Health will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio is 16.43%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. UMB Bank n.a. raised its holdings in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares during the last quarter. V Square Quantitative Management LLC raised its position in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the last quarter. Oakworth Capital Inc. bought a new position in Encompass Health during the 2nd quarter worth approximately $40,000. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health during the third quarter worth $40,000. Finally, Benjamin F. Edwards & Company Inc. raised its stake in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after buying an additional 198 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.